Efficacy of enoxacin and levofloxacin against Theileria annulata schizont-infected cell line
Abstract
Background: Theileriosis is a tick-borne disease that significantly hampers livestock industries in developing nations. Buparvaquone is the only available option for the management of theileriosis. On the other hand, drug use or organism evolution has led to the evolution of resistance over past twenty years. Treatment for theileriosis requires alternative therapeutic approaches. Aims: cultures, targeting the topoisomerase II pathway of organism. Methods: along with their cytotoxicity and hemolytic activity. Results: value of 26,49,031 µM compared to levofloxacin with 19,828 µM value. Conclusion: Levofloxacin showed satisfactory results compared to enoxacin. Further study is required along with other parameters to evaluate and assess the inhibitory activity of enoxacin and levofloxacin.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.